MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways (Q39426030)

11 September 2017

MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways (English)

1 reference

11 September 2017

1 reference

W Qin

1

1 reference

11 September 2017

P Dong

2

1 reference

11 September 2017

C Ma

3

1 reference

11 September 2017

K Mitchelson

4

1 reference

11 September 2017

T Deng

5

1 reference

11 September 2017

L Zhang

6

1 reference

11 September 2017

Y Sun

7

1 reference

11 September 2017

X Feng

8

1 reference

11 September 2017

Y Ding

9

1 reference

11 September 2017

X Lu

10

1 reference

11 September 2017

J He

11

1 reference

11 September 2017

H Wen

12

1 reference

11 September 2017

J Cheng

13

1 reference

11 September 2017

language of work or name

English

0 references

publication date

19 December 2011

1 reference

11 September 2017

1 reference

11 September 2017

31

1 reference

11 September 2017

36

1 reference

11 September 2017

4067-4075

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2011.561

11 September 2017

0 references

cites work

Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia: frequent PIK3CA amplification and AKT phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

MicroRNA-133 controls cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

Correlation of patterns of anchorage-independent growth with in vivo behavior of cells from a murine fibrosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

MAP kinase signalling pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

MicroRNAs: small RNAs with a big role in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

HPV vaccination for the prevention of cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

Expression of transketolase-like 1 (TKTL1) and p-Akt correlates with the progression of cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

Combinatorial microRNA target predictions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

Altered MicroRNA expression in cervical carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

Prediction of mammalian microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

Regulation of PTEN by Rho small GTPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

miRiad roles for the miR-17-92 cluster in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

PP2A: unveiling a reluctant tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

Myogenic factors that regulate expression of muscle-specific microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

The promise of global cervical-cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

AKT plays a central role in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

Stage-specific expression of microRNAs during Xenopus development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

Papillomaviruses and cancer: from basic studies to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

Pernicious papillomavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

MicroRNA profiling and head and neck cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.561

31 March 2020

Identifiers

DOI

10.1038/ONC.2011.561

1 reference

11 September 2017

1 reference